Table 1.
Demographic and Clinical Characteristics of Patients in the Discovery and Validation Cohorts According to LTS and STS Status
| Characteristics | LTS | STS |
|---|---|---|
| Discovery Cohort | ||
| (N = 22) | (N = 22) | |
| Median Age (years) | 50.5 (range: 22–74) | 50.5 (range: 28–72) |
| Percent Male | 59.1 | 63.6 |
| Percent College Graduatea | 45.5 | 23.8 |
| Median KPS Scorea | 90% | 80% |
| Median Year Diagnosed | 2010 | 2011 |
| Percent Completed Stupp Protocolb | 37 | 0 |
| Median Survival (Months) | 67.7 (range: 36–126) | 11.5 (range: 2.5–19) |
| Validation Cohort | ||
| (N = 15) | (N = 15) | |
| Median Age (years) | 50 (range: 23–68) | 62 (range: 23–78) |
| Percent Male | 67 | 60 |
| Median Education (years) | Unknown | Unknown |
| Median KPS Score | 90c | 90d |
| Median Year Diagnosed | 2009 | 2009 |
| Percent Completed Stupp Protocol | 66.7 | 26.7 |
| Median Survival (months) | 86.6 (range: 39–177) | 12.6 (range: 1.8–19) |
a 1 STS missing education; 3 LTS and 6 STS missing KPS score.
b As defined in PubMed PMID: 15758009. Results based on 20 LTS and 16 STS patients with complete information on receipt of the chemoradiation protocol. A total of 7 patients underwent biopsy as the only form of surgery (1 LTS and 6 STS).
c 10 missing values.
d 11 missing values.